158
Views
0
CrossRef citations to date
0
Altmetric
Research Article

First-in-Man trial of a drug-free bioresorbable stent designed to minimize the duration of coronary artery scaffolding

, , , , , & show all
Pages 1251-1266 | Received 25 Oct 2020, Accepted 24 Mar 2021, Published online: 21 Apr 2021

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.